Siemens Plans to Acquire PSE

News
Article

PSE, a supplier of advanced process modeling software and services, plans to become part of Siemens Digital Industries.

Process Systems Enterprise (PSE), a supplier of advanced process modeling software and services, announced in a Sept. 16, 2019 press release that it plans to be acquired by Siemens AG in a transaction scheduled to close in Q4 2019. The 160-member PSE operation will be integrated into the Process Automation Business Unit of Siemens Digital Industries, and the current PSE management team will remain in place.

PSE’s advanced process models, such as its gPROMS technology, are used within digital R&D, design, and operations in pharmaceutical and other process industries. PSE’s tools complement the Siemens portfolio in the process industry sector.

“The combination of high-fidelity predictive models and process data plays an increasingly important role in the digitalization of design and operations in the process industry,” said Eckard Eberle, CEO of the Siemens Process Automation Business Unit, in the press release. “It is important to take the process knowledge that is already available in product and process development and to map it in predictive models, which can then be used to add value in the digitalization environment in every step of the lifecycle. With PSE we will be even better equipped to meet the specific requirements of our process industry customers."

Siemens and PSE collaborated closely for two years before entering a strategic partnership in June 2018, developing new model-based solutions for applications including detailed unit operation design, plant monitoring and performance forecasting, soft sensing, nonlinear model-predictive control, and real-time optimization.

Both companies have agreed not to comment on the financial details of the transaction.

Source: PSE

Recent Videos
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content